Pfizer Inc.
PFE · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $62.6B | $63.6B | −1.6% |
| Operating income | $14.2B | $12.4B | +14.8% |
| Net income | $7.77B | $8.03B | −3.2% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 27, 2026 · filed Nov 3, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $16.6B | $16.7B | −0.4% |
| Operating income | $3.38B | $3.33B | +1.5% |
| Net income | $3.24B | $3.54B | −8.4% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Pfizer's revenue in FY2025?
- $62.6B in FY2025 (Fiscal year ended Dec 31, 2025), −1.6% vs $63.6B a year earlier, per its 10-K filed Feb 2026.
- Was Pfizer profitable in FY2025?
- Yes: net income was $7.77B and operating income $14.2B in FY2025.
- What was Pfizer's revenue in Q3 2026?
- $16.6B (−0.4% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.